Adam Rosenzweig

ORCID: 0009-0001-4059-9471
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Epigenetics and DNA Methylation
  • Cancer, Hypoxia, and Metabolism
  • Microbial Natural Products and Biosynthesis
  • Metabolism, Diabetes, and Cancer
  • Antimicrobial Peptides and Activities
  • Phytochemical compounds biological activities
  • Ubiquitin and proteasome pathways
  • ATP Synthase and ATPases Research
  • Metabolomics and Mass Spectrometry Studies
  • Genomics and Phylogenetic Studies
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Plant tissue culture and regeneration
  • Plant biochemistry and biosynthesis
  • Genomics and Chromatin Dynamics
  • RNA modifications and cancer

Rockefeller University
2023-2024

Tri-Institutional PhD Program in Chemical Biology
2024

Weill Cornell Medicine
2018-2022

Cornell University
2018-2022

Most biosynthetic gene clusters (BGCs) are functionally inaccessible by using fermentation methods. Bioinformatic-coupled total synthesis provides an alternative approach for accessing BGC-encoded bioactivities. To date, synthetic bioinformatic natural product (synBNP) methods have focused on lipopeptides containing simple lipids. Here we increase the and complexity of synBNP targeting BGCs that encode N-cinnamoyl This led to our cinnamosyn, a 10-mer N-cinnamoyl-containing peptide is...

10.1021/acs.orglett.4c00999 article EN Organic Letters 2024-05-20

Cilagicin is a dual polyprenyl phosphate binding lipodepsipeptide antibiotic with strong activity against clinically relevant Gram-positive pathogens while evading resistance. showed high serum that reduced its in vivo efficacy. Cilagicin-BP, which contains biphenyl moiety place of the N-terminal myristic acid found on cilagicin, and increased efficacy but decreased potency some pathogens. Here, we manipulated acyl tail peptide core cilagicin to identify an optimized collection structural...

10.1021/acsinfecdis.4c00018 article EN ACS Infectious Diseases 2024-04-16

Cilagicin is a Gram-positive active antibiotic that has dual polyprenyl phosphate binding mechanism impedes resistance development. Here we bioinformatically screened predicted non-ribosomal polypeptide synthetase encoded structures to search for antibiotics might similarly avoid Synthesis and bioactivity screening of the identified led three are against multidrug-resistant pathogens, two which, paenilagicin virgilagicin, did not lead even after prolonged exposure.

10.1021/acsinfecdis.3c00475 article EN ACS Infectious Diseases 2023-11-08

Summary From age 65 onwards, the risk of cancer incidence and associated mortality is substantially higher 1-3 . Nonetheless, our understanding complex relationship between still in its infancy 4 For decades, link has largely been attributed to increased exposure time mutagens older individuals. However, this view does not account for well-established role diet, exercise small molecules that target pace metabolic aging 5-8 Here, we show alterations occur with can render a systemic...

10.1101/2020.06.04.135087 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2020-06-05
Coming Soon ...